Cystoscopy at the time of benign hysterectomy: A decision analysis.

Document Type


Publication Date


Publication Title

American journal of obstetrics and gynecology


Cystoscopy; decision analysis; hysterectomy; urinary tract injury


BACKGROUND: Gynecologists debate the optimal use for intraoperative cystoscopy at the time of benign hysterectomy. Although adding cystoscopy leads to additional up-front cost, it may also enable intraoperative detection of a urinary tract injury that may otherwise go unnoticed. Prompt injury detection and intraoperative repair decreases morbidity and is less costly than postoperative diagnosis and treatment. Since urinary tract injury is rare and not easily studied in a prospective fashion, decision analysis provides a method for evaluating the cost associated with varying strategies for use of cystoscopy.

OBJECTIVE: To quantify costs of routine cystoscopy, selective cystoscopy, or no cystoscopy with benign hysterectomy.

STUDY DESIGN: We created a decision analysis model using TreeAge Pro. Separate models evaluated cystoscopy following abdominal, laparoscopic/robotic, and vaginal hysterectomy from the perspective of a third party payer. We modeled bladder and ureteral injuries detected intraoperatively and postoperatively. Ureteral injury detection included false positives and false negatives. Potential costs included diagnostics (imaging, repeat cystoscopy) and treatment (office/emergency room visits, readmission, ureteral stenting, cystotomy closure, ureteral reimplantation). Our model included costs of peritonitis, urinoma, and vesicovaginal/ureterovaginal fistula. Complication rates were determined from published literature. Costs were gathered from Medicare reimbursement as well as published literature when procedure codes could not accurately capture additional length of stay or work-up related to complications.

RESULTS: From prior studies, bladder injury incidence was 1.75%, 0.93%, and 2.91% for abdominal, laparoscopic/robotic, and vaginal hysterectomy. Ureteral injury incidence was 1.61%, 0.46%, and 0.46%. Hysterectomy costs without cystoscopy varied from $884.89-$1,121.91. Selective cystoscopy added $13.20-26.13 compared to no cystoscopy. Routine cystoscopy added $51.39-57.86 compared to selective cystoscopy. With increasing risk of injury, selective cystoscopy becomes cost-saving. When bladder injury exceeds 4.48-11.44% (based on surgical route) or ureteral injury exceeds 3.96-8.95%, selective cystoscopy costs less than no cystoscopy. Therefore, if surgeons estimate the risk of injury has exceeded these thresholds, cystoscopy may be cost-saving. However, for routine cystoscopy to be cost-saving, risk of bladder injury would need to exceed 20.59-47.24% and ureteral injury 27.22-37.72%. Model robustness was checked with multiple one-way sensitivity analyses, and no relevant thresholds for model variables other than injury rates were identified.

CONCLUSIONS: While routine cystoscopy increased cost $64.59-$83.99, selective cystoscopy had lower increases ($13.20-$26.13). These costs are reduced/eliminated with increasing risk of injury. Even a modest increase in suspicion for injury should prompt selective cystoscopy with benign hysterectomy.

Clinical Institute

Women & Children


Obstetrics & Gynecology